Company Directory › Robotics & hardware › Medtronic (Hugo RAS)
Profile not yet claimed. This profile was compiled by GlobleMatch from public sources on 6 November 2026. It has not been reviewed or endorsed by Medtronic (Hugo RAS), and a listing does not imply a partnership with GlobleMatch. If you represent Medtronic (Hugo RAS), you can claim this profile to verify and manage it — or request a correction or removal.
Directory Listing · Ireland
Medtronic (Hugo RAS)Not yet claimed
Medtronic is the world’s largest medical technology group, and its entry in surgical robotics is the Hugo robotic-assisted surgery (RAS) system, part of its Surgical business.
About Medtronic (Hugo RAS)
Medtronic is the world’s largest medical technology group, and its entry in surgical robotics is the Hugo robotic-assisted surgery (RAS) system, part of its Surgical business. Unveiled in 2019, Hugo is a modular soft-tissue robot: instead of a single boom, up to four independent arm carts are positioned around the operating table as a procedure requires, paired with an open surgeon console, a vision tower using Karl Storz imaging, and a wristed instrument portfolio drawn from Medtronic’s laparoscopic range. The system is wrapped in the Touch Surgery digital ecosystem, which records cases and provides performance analytics and training, plus a structured ASCEND training pathway and dedicated start-up and field-service support.
Hugo received its CE mark in Europe in 2021 and, on 3 December 2025, US FDA clearance for urologic procedures — prostatectomy, nephrectomy and cystectomy — with gynecologic and general-surgery indications being expanded in further markets. That makes Medtronic one of very few suppliers able to offer hospitals open, laparoscopic, robotic and digital surgery from a single vendor. For partners and hospital groups, Hugo matters as the principal large-scale challenger platform in soft-tissue robotic surgery, sold and serviced through Medtronic’s global surgical organisation.
Products & services
- Hugo robotic-assisted surgery system (modular robotic arm carts, open surgeon console, vision tower)
- Hugo instrument and accessory portfolio for urologic, gynecologic and general laparoscopic procedures
- Touch Surgery digital ecosystem (case recording, analytics and training)
- Hugo ASCEND training pathway, start-up specialists and field service support for hospital robotics programmes
Questions partners ask
Medtronic is the world’s largest medical technology group, and its entry in surgical robotics is the Hugo robotic-assisted surgery (RAS) system, part of its Surgical business. Its listed range includes Hugo robotic-assisted surgery system, Hugo instrument and accessory portfolio for urologic, gynecologic and general laparoscopic procedures, Touch Surgery digital ecosystem, Hugo ASCEND training pathway, start-up specialists and field service support for hospital robotics programmes.
Medtronic (Hugo RAS) is headquartered in Galway, Ireland. The Hugo system sits in Medtronic’s Surgical business. Its founding is recorded as: 2019 (Hugo RAS system unveiled; first commercial releases followed its 2021 European CE mark, and US FDA clearance for urologic procedures was granted on 3 December 2025. Parent Medtronic was founded in 1949).
Parent company Medtronic plc is listed on the New York Stock Exchange (NYSE: MDT); the Hugo programme is an internal business line, not a separately funded entity.
GlobleMatch Trust Signals
A directory that doesn’t sell stars. Trust Signals are built only from verifiable facts — never from anonymous ratings, and never for sale. There is no single hidden score.
| Public information coverage | 8 of 9 fields on the standard profile could be filled from public sources.This counts how much public information exists about the company — not how good the company is. The nine fields are listed in the methodology. Claiming the profile lets the company complete the remaining fields itself. |
|---|---|
| Last verified | 6 November 2026 — facts on this profile were checked against the sources listed below. Profiles are re-checked on a published 90-day cycle; this date is never quietly refreshed. |
Claim this profile to unlock response record, directory tenure and peer endorsements. The full methodology — what each signal measures and how it is calculated — is published in the Trust Signals methodology, including a change log.
Sources & verification
- Company website — medtronic.com (official site: profile facts, headquarters, markets and product range). Checked 6 November 2026.
- Figures described in this profile as company-stated come from the company’s own public materials and were not independently audited by GlobleMatch.
Facts last verified: 6 November 2026. Something wrong? A listed company can request a correction or removal at any time; verified requests are actioned.
Related companies
More in Robotics & hardware: MicroVision (lidar sensors & perception solutions, United States) · Mitsubishi Electric (MELFA) (articulated, scara and collaborative (melfa brand, factory automation systems division of mitsubishi electric), Japan) · Nilfisk (professional cleaning equipment & autonomous cleaning machines, Denmark)
Robotics on GlobleMatch: the GlobleMatch Robotics 100 programme tracks leading robotics companies worldwide, and claimed directory profiles can be considered for its seats.
Profile facts
| Headquarters | Galway, Ireland (Medtronic plc legal headquarters; operational headquarters in Minneapolis, Minnesota, United States). The Hugo system sits in Medtronic’s Surgical business |
|---|---|
| Country | Ireland |
| Industry | Surgical robotics — soft-tissue robotic-assisted surgery (Medtronic plc) |
| Founded | 2019 (Hugo RAS system unveiled; first commercial releases followed its 2021 European CE mark, and US FDA clearance for urologic procedures was granted on 3 December 2025. Parent Medtronic was founded in 1949) |
| Company size | — (not publicly disclosed; left blank rather than guessed) |
| Markets served | Global; Hugo is commercially available across Europe, Latin America, Asia-Pacific and other regions, with the US launch under way following FDA clearance |
| Official website | medtronic.com |
| Public funding | Parent company Medtronic plc is listed on the New York Stock Exchange (NYSE: MDT); the Hugo programme is an internal business line, not a separately funded entity |
| Profile status | Not yet claimed |
| Facts last verified | 6 November 2026 |
Represent Medtronic (Hugo RAS)?
Claiming this profile is free. Once your claim is verified, you get:
- Verified badge — on this profile
- Edit rights — intro, logo, photos, website and contact button
- Correction channel — for any fact that is wrong
- Free AI Search Visibility Snapshot — the full report on how AI search engines describe your company
- GlobleMatch badge pack — for your own website
- “Recently Claimed” announcement — in the directory
- Path to a showcase profile — and Founding Claimer highlight for early claimers
Verified with a company-domain email or proof on your official website or social profile. One claim per company; benefits activate after verification.
Not your company, or want it removed? Request a correction or removal.